Supernus Pharmaceuticals | SUPN - 贷款资金

金融业

USD

USD 1.5B

现金及等价物

USD 184.87M

USD 49.04M

USD 731.58M

USD 373.93M

USD 40.98M

USD -35.25M

USD 29.23M

674

EPS每股收益

USD 0.6

股本和储备

USD 1.08B

USD 129.36M

债务利息支出

USD 910K

USD 2.02M

USD 400.38M

USD 2.53B

USD -2.29M

USD 1.08B

USD -35.25M

普通股股本

USD 58.04M

44.21

USD -5.95M

USD 207.71M

销售和管理费用

USD 118.23M

USD 110.77M

贸易债权人

USD 10.17M

应收帐款人

USD 182.18M

	贷款资金	更改		日
Abbott	USD 29.64B		19.74B	2026-03
ANI Pharmaceuticals	USD 286M		5.84M	2026-03
Aurora Cannabis	CAD 18.13M		15.07M	2026-03
Bristol-Myers Squibb	USD 42.15B		698M	2026-03
Canopy Growth	CAD 217.12M		7.87M	2026-03
Cara Therapeutics	USD 0		0	2025-03
Eisai	JPY 134.78B		12M	2026-03
Eli Lilly	USD 39.37B		1.5B	2026-03
Novo Nordisk	DKK 119.17B		231M	2026-03
Pacira	USD 367.66M		4.53M	2026-03
Perrigo	USD 3.62B		17.5M	2026-03
Pfizer	USD 60.57B		1.08B	2026-03
Supernus Pharmaceuticals	USD 400.38M		21.13M	2022-03
United Therapeutics	USD 100M		100M	2024-06
Xeris Pharmaceuticals	USD 221.22M		889K	2026-03